| Execution period | Quarter ended 31st March, 2026 |
|---|
BSE filing, NSE: AJANTSOY. Summary written from the filing by ALFA Finder's alert engine.
Ajanta Soya Ltd: key numbers
- Share price
- ₹20.70
- Market cap
- ₹166.6 Cr
- Revenue (annual)
- ₹1,308 Cr
- Net profit (annual)
- ₹8.38 Cr
- P/E (TTM)
- 11.6×Sector 38.6×
- Promoter holding
- 49.80%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ajanta Soya Ltd
All →Ajanta Soya Promoter Buying (Off-Market)
Ajanta Soya Ltd disclosed an off-market inter-se transfer where Mrs. Chander Kala Goyal gifted 36.93% of the company's equity shares to CKG Family Trust.
- Promoter stake change
- +36.93%
Ajanta Soya Management Change
Ajanta Soya Limited announced the resignation of Mr. Anil Kumar Rana as the Chief Financial Officer and Key Managerial Personnel, effective October 11, 2026.
Ajanta Soya Management Change
Ajanta Soya Limited announced the reappointment of Mr. Sushil Kumar Goyal as Managing Director and Mr. Abhey Goyal as Whole-time Director for three-year terms.
Ajanta Soya Annual General Meeting
Ajanta Soya Limited successfully conducted its 35th Annual General Meeting on September 28, 2026, through video conferencing to transact ordinary and special business.
Ajanta Soya Promoter Selling (Off-Market)
Promoter Chander Kala Goyal transferred 2.97 crore shares of Ajanta Soya Limited to the CKG Family Trust through an off-market inter-se gift.
Ajanta Soya Promoter Buying (Off-Market)
Promoter Chander Kala Goyal acquired 51.02% of CAMWPL by gift, an entity holding 11.18% of Ajanta Soya. The off-market inter-se transfer triggers SAST Reg 29(2) disclosure.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.